LNCaP Xenografts
Rincon Bio performs LNCaP xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Prostate
DU-LNCaP cells were derived from 50 year old male Caucasian with carcinoma
Notes
Genes expressed: human prostatic acid phosphatase; prostate specific antigen
Receptor Expression: androgen receptor, positive; estrogen receptor, positive
in vivo
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Request Quote
Receive a quote within one business day for a LNCaP Xenograft
Rincon Bio Growth Curve
Cell Line: LNCaP
Mouse Strain: Nod-Scid Gamma from Jackson, Male
Animals per Group: 5
Positive Control: None
Concentration: N/A
Matrigel: Yes
Dosing schedule: N/A
Cells Implanted per Animal: 5.5 million
Stratified: N/A
Stratification size: N/A
Days from implant to stratification: N/A
WHY WORK WITH
RINCON BIO?
DOMESTIC QUALITY at COMPETITIVE PRICES
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
PERSONAL TOUCH
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.